Evaluation of TH104 for Moderate to Severe Pruritus in Primary Biliary Cholangitis: a Double-blind, Randomized, Placebo-controlled, Phase 2a Study
Latest Information Update: 20 Dec 2024
At a glance
- Drugs Nalmefene (Primary)
- Indications Eczema; Pruritus
- Focus Adverse reactions
- Sponsors Avior Bio; Tharimmune
Most Recent Events
- 15 Dec 2024 Status changed from planning to not yet recruiting.
- 19 Mar 2021 New trial record